Duncan Gregory Scott 4
4 · Virios Therapeutics, Inc. · Filed Dec 22, 2021
Insider Transaction Report
Form 4
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2021-12-21$5.52/sh+5,000$27,615→ 24,961 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.395 to $5.708, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.